Peter Behner is of MiNK Therapeutics, Inc.. Currently has a direct ownership of 109,234 shares of INKT, which is worth approximately $80,833. The most recent transaction as insider was on Sep 03, 2024, when has been sold 18,753 shares (Common Stock) at a price of $0.82 per share, resulting in proceeds of $15,377. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 109K
20.73% 3M change
147.93% 12M change
Total Value Held $80,833

Peter Behner Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 03 2024
BUY
Grant, award, or other acquisition
$15,377 $0.82 p/Share
18,753 Added 14.65%
109,234 Common Stock
Jun 03 2024
BUY
Grant, award, or other acquisition
$15,299 $0.99 p/Share
15,454 Added 14.59%
90,481 Common Stock
Mar 01 2024
BUY
Grant, award, or other acquisition
$15,375 $0.95 p/Share
16,185 Added 17.74%
75,027 Common Stock
Dec 01 2023
BUY
Grant, award, or other acquisition
$15,375 $1.04 p/Share
14,784 Added 20.08%
58,842 Common Stock
Sep 01 2023
BUY
Grant, award, or other acquisition
$15,375 $1.46 p/Share
10,531 Added 19.29%
44,058 Common Stock
Jun 01 2023
BUY
Grant, award, or other acquisition
$15,375 $1.76 p/Share
8,736 Added 20.58%
33,721 Common Stock
Mar 01 2023
BUY
Grant, award, or other acquisition
$15,376 $2.09 p/Share
7,357 Added 22.75%
24,985 Common Stock
Dec 01 2022
BUY
Grant, award, or other acquisition
$15,375 $2.61 p/Share
5,891 Added 25.05%
17,628 Common Stock
Sep 15 2022
BUY
Grant, award, or other acquisition
$30,751 $2.62 p/Share
11,737 Added 50.0%
11,737 Common Stock
PB

Peter Behner

New York, NY

Track Institutional and Insider Activities on INKT

Follow MiNK Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells INKT shares.

Notify only if

Insider Trading

Get notified when an Mi Nk Therapeutics, Inc. insider buys or sells INKT shares.

Notify only if

News

Receive news related to MiNK Therapeutics, Inc.

Track Activities on INKT